Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Aug 27, 2018 12:27pm
162 Views
Post# 28522988

RE:Short Interest on NASDAQ

RE:Short Interest on NASDAQ
SPCEO1 wrote: The latest report for mid August is now available for NASDAQ and it showed short interest increased by 196,000 shares and that total short interest there is now 1,1 million shares or about 1.5% of the float. So, that is where some of the selling has come from that has pressured the stock oddly lower (at least thru 8/15).

Don't know what would be motivating the seller and a 1.5% short position is not a large one, but someone must feel like they know something that is going to send the stock lower still. It is worth noting that shorts, like longs, make mistakes.   


Is that 196,000 shorted shares for a single week/2 week//month period? That would be roughly a couple of days worth of shares traded in US. So while its only 1.5% of the float its likely a good proportion of recent trades.

Bullboard Posts